AI in healthcare and life sciences: key considerations
Written By
Senior Associate
UK
I am a senior associate in Bird & Bird's London-based Commercial Group. My practice principally involves advising clients on complex projects (including major public sector programmes and transformational outsourcings) and on a range of technology matters. More broadly, I advise on a variety of supply and services agreements across a number of sectors, with a particular focus on the Life Sciences & Healthcare and Defence sectors.
Related
Practices
Sectors
Trending Topics
Regions
Digital technology is changing the way in which we receive healthcare. Healthcare providers are increasingly looking to adopt digital technologies such as Artificial Intelligence (AI) as the benefits become clear. AI is particularly attractive given its ability to analyse large quantities of complex data. The NHS’s commitment to AI is demonstrated through the NHS AI Lab, which brings together government, health and care providers, academics and technology companies with the aim of accelerating the safe adoption of AI in health and care.
AI provides a myriad of opportunities for healthcare and life sciences, but also a few key challenges to navigate and understand.
Latest insights
More Insights
VAT in the Digital Age (“ViDA”): prepare your business with Bird & Bird – 10 key insights for success
Nov 15 2024
Hungary: Easing the tax burden of innovative startups – from January 2025, the IP contributions will become tax-free
Nov 14 2024
Women in Tech: At the forefront of innovation - Key takeaways from Andrea Wu, Urban-Air Port
Nov 12 2024